Velocity Clinical Research Inc.

Durham, NC Professional servicesNAICS 541700

Self-funded health planPlan year 2025Renews January
1,454Participants-8% vs. prior year
$3.4MEst. pharmacy spend / yrParticipants × national avg.
Jan 2027Next renewalPlan year begins January 1
#7 of 24Professional services in NCBy participants

Overview

Velocity Clinical Research Inc. sponsors a self-funded health plan that covered 1,454 participants in plan year 2025, down 8% from the prior year. The plan year starts in January. Alongside medical, its benefits filing reports life insurance, dental, vision, short-term disability, and more.

Plan type
ERISA welfare benefit plan, self-funded (benefits paid from employer assets or a trust)
Participants
1,454 · prior year 1,577
Plan year
Begins January 1 · next renewal January 2027
Health plans filed
Velocity Clinical Research, Inc. Employee Benefit Plan, plan 501 (1,454 participants)
Stop-loss carrier
Cigna Health and Life Insurance Company and Affiliates
Broker compensation
$186K across insured contracts
MedicalLife insuranceDentalVisionShort-term disabilityLong-term disabilityOther welfare benefits

Insurance carriers

Insured coverage reported on Schedule A. Self-funded medical claims aren't reported there.

CarrierCoverageCoveredPremiumBroker comp
Unum Life Insurance Company of AmericaLife, Short-term disability, Long-term disability830$1.4M$115K
Cigna Health and Life Insurance Company and AffiliatesStop-loss609$614K—
Delta Dental of North CarolinaDental1,256$492K$50K
Kaiser Foundation Health Plan Inc.Medical, HMO30$282K$20K
Unum Insurance CompanySpecific Disease, Accident, Hospital185$115K$11K
First Unum Life Insurance CompanyShort-term disability26$2K$835

Pharmacy benefit estimate

StreamRX estimate for a plan this size. Not based on this plan's claims.

$3.4M/ year

Estimated prescription spend: 1,454 participants × $2,371 national average per member. Usually higher once dependents are counted.

$90K–$221K/ year

Typical savings opportunity found in independent reviews of plans this size.

Brands with a generic available$26K–$66K
Lower-cost therapeutic alternatives$38K–$80K
Generic pricing vs. actual cost$17K–$50K
PBM contract terms$9K–$26K
The DOL's PBM fee disclosure rule first applies to this plan for the plan year beginning January 2028: semiannual PBM compensation reports and an annual audit right.

Form 5500 filing details

Filing
Form 5500 with Schedule A, plan year 2025
Plan sponsor
Velocity Clinical Research Inc.
Sponsor EIN
82-3171064
Plan number
501
Filed with
U.S. Department of Labor (EBSA) via EFAST2

Verify this filing: search EIN 82-3171064 in the Department of Labor's EFAST2 Form 5500 search.

Retirement plan

Plan
Velocity Clinical Research 401(k) Plan
Type
401(k) plan
Participants
1,393

About this data

Source: Velocity Clinical Research Inc.'s Form 5500 filing for plan year 2025 and its Schedule A insurance reports, published by the U.S. Department of Labor. "Self-funded" means the filing reports benefits paid from employer assets or a trust, with no medical insurance contract or with a stop-loss contract. Pharmacy figures are StreamRX estimates based on national averages. StreamRX is not affiliated with Velocity Clinical Research Inc..

Request a correction · Methodology